nodes	percent_of_prediction	percent_of_DWPC	metapath
Dactinomycin—ABCC6—Teniposide—lymphatic system cancer	0.409	0.493	CbGbCtD
Dactinomycin—ABCC1—Mitoxantrone—lymphatic system cancer	0.0843	0.102	CbGbCtD
Dactinomycin—ABCG2—Teniposide—lymphatic system cancer	0.0807	0.0974	CbGbCtD
Dactinomycin—ABCC1—Vincristine—lymphatic system cancer	0.058	0.07	CbGbCtD
Dactinomycin—ABCG2—Mitoxantrone—lymphatic system cancer	0.0564	0.0681	CbGbCtD
Dactinomycin—ABCG2—Vincristine—lymphatic system cancer	0.0388	0.0469	CbGbCtD
Dactinomycin—ABCC1—Methotrexate—lymphatic system cancer	0.0351	0.0424	CbGbCtD
Dactinomycin—ABCG2—Methotrexate—lymphatic system cancer	0.0235	0.0284	CbGbCtD
Dactinomycin—ABCB1—Mitoxantrone—lymphatic system cancer	0.0203	0.0246	CbGbCtD
Dactinomycin—ABCB1—Vincristine—lymphatic system cancer	0.014	0.0169	CbGbCtD
Dactinomycin—ABCB1—Methotrexate—lymphatic system cancer	0.00848	0.0102	CbGbCtD
Dactinomycin—ABCC6—Podofilox—Teniposide—lymphatic system cancer	0.00496	1	CbGdCrCtD
Dactinomycin—Necrosis—Mitoxantrone—lymphatic system cancer	0.00109	0.00653	CcSEcCtD
Dactinomycin—Extravasation—Carmustine—lymphatic system cancer	0.00105	0.00632	CcSEcCtD
Dactinomycin—Erythema multiforme—Mechlorethamine—lymphatic system cancer	0.00105	0.00631	CcSEcCtD
Dactinomycin—Extravasation—Vincristine—lymphatic system cancer	0.00101	0.00603	CcSEcCtD
Dactinomycin—Alopecia—Mechlorethamine—lymphatic system cancer	0.000983	0.0059	CcSEcCtD
Dactinomycin—Extravasation—Mitoxantrone—lymphatic system cancer	0.000979	0.00588	CcSEcCtD
Dactinomycin—Pancytopenia—Teniposide—lymphatic system cancer	0.000973	0.00584	CcSEcCtD
Dactinomycin—Liver function test abnormal—Fludarabine—lymphatic system cancer	0.000962	0.00578	CcSEcCtD
Dactinomycin—Neutropenia—Teniposide—lymphatic system cancer	0.000958	0.00575	CcSEcCtD
Dactinomycin—Toxic epidermal necrolysis—Fludarabine—lymphatic system cancer	0.000938	0.00563	CcSEcCtD
Dactinomycin—Hypocalcaemia—Mitoxantrone—lymphatic system cancer	0.000933	0.0056	CcSEcCtD
Dactinomycin—Raised liver function tests—Methotrexate—lymphatic system cancer	0.000922	0.00553	CcSEcCtD
Dactinomycin—Ulcerative stomatitis—Methotrexate—lymphatic system cancer	0.000922	0.00553	CcSEcCtD
Dactinomycin—Ulcer—Mitoxantrone—lymphatic system cancer	0.000903	0.00542	CcSEcCtD
Dactinomycin—Dysphagia—Fludarabine—lymphatic system cancer	0.000901	0.00541	CcSEcCtD
Dactinomycin—Stomatitis—Teniposide—lymphatic system cancer	0.000891	0.00535	CcSEcCtD
Dactinomycin—Phlebitis—Bleomycin—lymphatic system cancer	0.000887	0.00532	CcSEcCtD
Dactinomycin—Leukopenia—Mechlorethamine—lymphatic system cancer	0.000867	0.0052	CcSEcCtD
Dactinomycin—Pancytopenia—Fludarabine—lymphatic system cancer	0.000855	0.00513	CcSEcCtD
Dactinomycin—Neutropenia—Fludarabine—lymphatic system cancer	0.000842	0.00506	CcSEcCtD
Dactinomycin—Pneumonia—Fludarabine—lymphatic system cancer	0.000808	0.00485	CcSEcCtD
Dactinomycin—Sepsis—Carmustine—lymphatic system cancer	0.000797	0.00479	CcSEcCtD
Dactinomycin—Stevens-Johnson syndrome—Fludarabine—lymphatic system cancer	0.000796	0.00478	CcSEcCtD
Dactinomycin—Mouth ulceration—Vincristine—lymphatic system cancer	0.000793	0.00476	CcSEcCtD
Dactinomycin—Infection—Mechlorethamine—lymphatic system cancer	0.000785	0.00471	CcSEcCtD
Dactinomycin—Stomatitis—Fludarabine—lymphatic system cancer	0.000783	0.0047	CcSEcCtD
Dactinomycin—Phlebitis—Carmustine—lymphatic system cancer	0.000774	0.00465	CcSEcCtD
Dactinomycin—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.000774	0.00465	CcSEcCtD
Dactinomycin—Flushing—Teniposide—lymphatic system cancer	0.000761	0.00457	CcSEcCtD
Dactinomycin—Anorexia—Mechlorethamine—lymphatic system cancer	0.000754	0.00452	CcSEcCtD
Dactinomycin—Sepsis—Mitoxantrone—lymphatic system cancer	0.000741	0.00445	CcSEcCtD
Dactinomycin—Chills—Teniposide—lymphatic system cancer	0.000736	0.00442	CcSEcCtD
Dactinomycin—Alopecia—Teniposide—lymphatic system cancer	0.000725	0.00435	CcSEcCtD
Dactinomycin—Phlebitis—Mitoxantrone—lymphatic system cancer	0.00072	0.00432	CcSEcCtD
Dactinomycin—Pharyngitis—Fludarabine—lymphatic system cancer	0.000716	0.00429	CcSEcCtD
Dactinomycin—Hepatic failure—Vincristine—lymphatic system cancer	0.000709	0.00425	CcSEcCtD
Dactinomycin—Febrile neutropenia—Methotrexate—lymphatic system cancer	0.000707	0.00425	CcSEcCtD
Dactinomycin—Eruption—Methotrexate—lymphatic system cancer	0.000692	0.00415	CcSEcCtD
Dactinomycin—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.000687	0.00412	CcSEcCtD
Dactinomycin—Erythema multiforme—Fludarabine—lymphatic system cancer	0.000682	0.00409	CcSEcCtD
Dactinomycin—Folliculitis—Methotrexate—lymphatic system cancer	0.000677	0.00406	CcSEcCtD
Dactinomycin—Anaemia—Teniposide—lymphatic system cancer	0.00066	0.00396	CcSEcCtD
Dactinomycin—Chills—Fludarabine—lymphatic system cancer	0.000647	0.00388	CcSEcCtD
Dactinomycin—Leukopenia—Teniposide—lymphatic system cancer	0.000639	0.00384	CcSEcCtD
Dactinomycin—Alopecia—Fludarabine—lymphatic system cancer	0.000637	0.00382	CcSEcCtD
Dactinomycin—Pancytopenia—Bleomycin—lymphatic system cancer	0.000627	0.00376	CcSEcCtD
Dactinomycin—Liver function test abnormal—Carmustine—lymphatic system cancer	0.000616	0.0037	CcSEcCtD
Dactinomycin—Pneumonia—Bleomycin—lymphatic system cancer	0.000592	0.00355	CcSEcCtD
Dactinomycin—Oedema—Teniposide—lymphatic system cancer	0.000583	0.0035	CcSEcCtD
Dactinomycin—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.000582	0.0035	CcSEcCtD
Dactinomycin—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.000582	0.0035	CcSEcCtD
Dactinomycin—Anaemia—Fludarabine—lymphatic system cancer	0.00058	0.00348	CcSEcCtD
Dactinomycin—Infection—Teniposide—lymphatic system cancer	0.000579	0.00348	CcSEcCtD
Dactinomycin—Dysphagia—Carmustine—lymphatic system cancer	0.000576	0.00346	CcSEcCtD
Dactinomycin—Stomatitis—Bleomycin—lymphatic system cancer	0.000574	0.00345	CcSEcCtD
Dactinomycin—Aspartate aminotransferase increased—Vincristine—lymphatic system cancer	0.000573	0.00344	CcSEcCtD
Dactinomycin—Thrombocytopenia—Teniposide—lymphatic system cancer	0.000571	0.00342	CcSEcCtD
Dactinomycin—Malaise—Fludarabine—lymphatic system cancer	0.000566	0.0034	CcSEcCtD
Dactinomycin—Leukopenia—Fludarabine—lymphatic system cancer	0.000562	0.00337	CcSEcCtD
Dactinomycin—Aspartate aminotransferase increased—Mitoxantrone—lymphatic system cancer	0.000558	0.00335	CcSEcCtD
Dactinomycin—Anorexia—Teniposide—lymphatic system cancer	0.000556	0.00333	CcSEcCtD
Dactinomycin—Hepatotoxicity—Methotrexate—lymphatic system cancer	0.000551	0.00331	CcSEcCtD
Dactinomycin—Pancytopenia—Carmustine—lymphatic system cancer	0.000547	0.00329	CcSEcCtD
Dactinomycin—Necrosis—Methotrexate—lymphatic system cancer	0.000542	0.00325	CcSEcCtD
Dactinomycin—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.000541	0.00325	CcSEcCtD
Dactinomycin—Neutropenia—Carmustine—lymphatic system cancer	0.000539	0.00324	CcSEcCtD
Dactinomycin—Myalgia—Fludarabine—lymphatic system cancer	0.000534	0.00321	CcSEcCtD
Dactinomycin—Discomfort—Fludarabine—lymphatic system cancer	0.000528	0.00317	CcSEcCtD
Dactinomycin—Pancytopenia—Vincristine—lymphatic system cancer	0.000523	0.00314	CcSEcCtD
Dactinomycin—Pneumonia—Carmustine—lymphatic system cancer	0.000517	0.0031	CcSEcCtD
Dactinomycin—Neutropenia—Vincristine—lymphatic system cancer	0.000515	0.00309	CcSEcCtD
Dactinomycin—Oedema—Fludarabine—lymphatic system cancer	0.000512	0.00307	CcSEcCtD
Dactinomycin—Pancytopenia—Mitoxantrone—lymphatic system cancer	0.000509	0.00305	CcSEcCtD
Dactinomycin—Infection—Fludarabine—lymphatic system cancer	0.000509	0.00305	CcSEcCtD
Dactinomycin—Decreased appetite—Teniposide—lymphatic system cancer	0.000507	0.00304	CcSEcCtD
Dactinomycin—Vomiting—Mechlorethamine—lymphatic system cancer	0.000503	0.00302	CcSEcCtD
Dactinomycin—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.000502	0.00301	CcSEcCtD
Dactinomycin—Neutropenia—Mitoxantrone—lymphatic system cancer	0.000501	0.00301	CcSEcCtD
Dactinomycin—Stomatitis—Carmustine—lymphatic system cancer	0.000501	0.00301	CcSEcCtD
Dactinomycin—Rash—Mechlorethamine—lymphatic system cancer	0.000498	0.00299	CcSEcCtD
Dactinomycin—Pneumonia—Vincristine—lymphatic system cancer	0.000494	0.00296	CcSEcCtD
Dactinomycin—Flushing—Bleomycin—lymphatic system cancer	0.000491	0.00294	CcSEcCtD
Dactinomycin—Anorexia—Fludarabine—lymphatic system cancer	0.000488	0.00293	CcSEcCtD
Dactinomycin—Extravasation—Methotrexate—lymphatic system cancer	0.000488	0.00293	CcSEcCtD
Dactinomycin—Pneumonia—Mitoxantrone—lymphatic system cancer	0.000481	0.00288	CcSEcCtD
Dactinomycin—Feeling abnormal—Teniposide—lymphatic system cancer	0.00048	0.00288	CcSEcCtD
Dactinomycin—Stomatitis—Vincristine—lymphatic system cancer	0.000478	0.00287	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.000477	0.00286	CcSEcCtD
Dactinomycin—Chills—Bleomycin—lymphatic system cancer	0.000474	0.00285	CcSEcCtD
Dactinomycin—Nausea—Mechlorethamine—lymphatic system cancer	0.00047	0.00282	CcSEcCtD
Dactinomycin—Alopecia—Bleomycin—lymphatic system cancer	0.000467	0.0028	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.000467	0.0028	CcSEcCtD
Dactinomycin—Stomatitis—Mitoxantrone—lymphatic system cancer	0.000466	0.0028	CcSEcCtD
Dactinomycin—Abdominal pain—Teniposide—lymphatic system cancer	0.000461	0.00277	CcSEcCtD
Dactinomycin—Body temperature increased—Teniposide—lymphatic system cancer	0.000461	0.00277	CcSEcCtD
Dactinomycin—Erythema—Bleomycin—lymphatic system cancer	0.00046	0.00276	CcSEcCtD
Dactinomycin—Ulcer—Methotrexate—lymphatic system cancer	0.00045	0.0027	CcSEcCtD
Dactinomycin—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.000446	0.00268	CcSEcCtD
Dactinomycin—Decreased appetite—Fludarabine—lymphatic system cancer	0.000445	0.00267	CcSEcCtD
Dactinomycin—Fatigue—Fludarabine—lymphatic system cancer	0.000442	0.00265	CcSEcCtD
Dactinomycin—Pain—Fludarabine—lymphatic system cancer	0.000438	0.00263	CcSEcCtD
Dactinomycin—Hypersensitivity—Teniposide—lymphatic system cancer	0.000429	0.00258	CcSEcCtD
Dactinomycin—Hepatitis—Mitoxantrone—lymphatic system cancer	0.000429	0.00257	CcSEcCtD
Dactinomycin—Flushing—Carmustine—lymphatic system cancer	0.000428	0.00257	CcSEcCtD
Dactinomycin—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.000427	0.00256	CcSEcCtD
Dactinomycin—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.000426	0.00256	CcSEcCtD
Dactinomycin—Anaemia—Bleomycin—lymphatic system cancer	0.000425	0.00255	CcSEcCtD
Dactinomycin—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000422	0.00253	CcSEcCtD
Dactinomycin—Asthenia—Teniposide—lymphatic system cancer	0.000418	0.00251	CcSEcCtD
Dactinomycin—Malaise—Bleomycin—lymphatic system cancer	0.000415	0.00249	CcSEcCtD
Dactinomycin—Leukopenia—Bleomycin—lymphatic system cancer	0.000412	0.00247	CcSEcCtD
Dactinomycin—Alopecia—Carmustine—lymphatic system cancer	0.000408	0.00245	CcSEcCtD
Dactinomycin—Body temperature increased—Fludarabine—lymphatic system cancer	0.000405	0.00243	CcSEcCtD
Dactinomycin—Erythema—Carmustine—lymphatic system cancer	0.000402	0.00241	CcSEcCtD
Dactinomycin—Aplastic anaemia—Methotrexate—lymphatic system cancer	0.0004	0.0024	CcSEcCtD
Dactinomycin—Diarrhoea—Teniposide—lymphatic system cancer	0.000399	0.00239	CcSEcCtD
Dactinomycin—Myalgia—Bleomycin—lymphatic system cancer	0.000392	0.00235	CcSEcCtD
Dactinomycin—Alopecia—Vincristine—lymphatic system cancer	0.000389	0.00234	CcSEcCtD
Dactinomycin—Discomfort—Bleomycin—lymphatic system cancer	0.000387	0.00232	CcSEcCtD
Dactinomycin—Chills—Mitoxantrone—lymphatic system cancer	0.000385	0.00231	CcSEcCtD
Dactinomycin—Mouth ulceration—Methotrexate—lymphatic system cancer	0.000385	0.00231	CcSEcCtD
Dactinomycin—Alopecia—Mitoxantrone—lymphatic system cancer	0.000379	0.00228	CcSEcCtD
Dactinomycin—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000377	0.00227	CcSEcCtD
Dactinomycin—Oedema—Bleomycin—lymphatic system cancer	0.000376	0.00225	CcSEcCtD
Dactinomycin—Erythema—Mitoxantrone—lymphatic system cancer	0.000373	0.00224	CcSEcCtD
Dactinomycin—Infection—Bleomycin—lymphatic system cancer	0.000373	0.00224	CcSEcCtD
Dactinomycin—Anaemia—Carmustine—lymphatic system cancer	0.000371	0.00223	CcSEcCtD
Dactinomycin—Vomiting—Teniposide—lymphatic system cancer	0.000371	0.00222	CcSEcCtD
Dactinomycin—Sepsis—Methotrexate—lymphatic system cancer	0.000369	0.00222	CcSEcCtD
Dactinomycin—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000368	0.00221	CcSEcCtD
Dactinomycin—Asthenia—Fludarabine—lymphatic system cancer	0.000368	0.00221	CcSEcCtD
Dactinomycin—Rash—Teniposide—lymphatic system cancer	0.000367	0.00221	CcSEcCtD
Dactinomycin—Leukopenia—Carmustine—lymphatic system cancer	0.00036	0.00216	CcSEcCtD
Dactinomycin—Anorexia—Bleomycin—lymphatic system cancer	0.000358	0.00215	CcSEcCtD
Dactinomycin—Anaemia—Vincristine—lymphatic system cancer	0.000354	0.00213	CcSEcCtD
Dactinomycin—Diarrhoea—Fludarabine—lymphatic system cancer	0.00035	0.0021	CcSEcCtD
Dactinomycin—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000346	0.00208	CcSEcCtD
Dactinomycin—Nausea—Teniposide—lymphatic system cancer	0.000346	0.00208	CcSEcCtD
Dactinomycin—Anaemia—Mitoxantrone—lymphatic system cancer	0.000345	0.00207	CcSEcCtD
Dactinomycin—Hepatic failure—Methotrexate—lymphatic system cancer	0.000344	0.00206	CcSEcCtD
Dactinomycin—Leukopenia—Vincristine—lymphatic system cancer	0.000343	0.00206	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000342	0.00205	CcSEcCtD
Dactinomycin—Myalgia—Carmustine—lymphatic system cancer	0.000342	0.00205	CcSEcCtD
Dactinomycin—Malaise—Mitoxantrone—lymphatic system cancer	0.000337	0.00202	CcSEcCtD
Dactinomycin—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000334	0.00201	CcSEcCtD
Dactinomycin—Oedema—Carmustine—lymphatic system cancer	0.000328	0.00197	CcSEcCtD
Dactinomycin—Decreased appetite—Bleomycin—lymphatic system cancer	0.000326	0.00196	CcSEcCtD
Dactinomycin—Myalgia—Vincristine—lymphatic system cancer	0.000326	0.00196	CcSEcCtD
Dactinomycin—Infection—Carmustine—lymphatic system cancer	0.000326	0.00195	CcSEcCtD
Dactinomycin—Vomiting—Fludarabine—lymphatic system cancer	0.000326	0.00195	CcSEcCtD
Dactinomycin—Rash—Fludarabine—lymphatic system cancer	0.000323	0.00194	CcSEcCtD
Dactinomycin—Pain—Bleomycin—lymphatic system cancer	0.000321	0.00193	CcSEcCtD
Dactinomycin—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000321	0.00193	CcSEcCtD
Dactinomycin—Myalgia—Mitoxantrone—lymphatic system cancer	0.000318	0.00191	CcSEcCtD
Dactinomycin—Lethargy—Methotrexate—lymphatic system cancer	0.000315	0.00189	CcSEcCtD
Dactinomycin—Discomfort—Mitoxantrone—lymphatic system cancer	0.000314	0.00189	CcSEcCtD
Dactinomycin—Oedema—Vincristine—lymphatic system cancer	0.000313	0.00188	CcSEcCtD
Dactinomycin—Anorexia—Carmustine—lymphatic system cancer	0.000312	0.00188	CcSEcCtD
Dactinomycin—Infection—Vincristine—lymphatic system cancer	0.000311	0.00187	CcSEcCtD
Dactinomycin—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000309	0.00186	CcSEcCtD
Dactinomycin—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000306	0.00184	CcSEcCtD
Dactinomycin—Oedema—Mitoxantrone—lymphatic system cancer	0.000305	0.00183	CcSEcCtD
Dactinomycin—Nausea—Fludarabine—lymphatic system cancer	0.000304	0.00183	CcSEcCtD
Dactinomycin—Infection—Mitoxantrone—lymphatic system cancer	0.000303	0.00182	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000299	0.00179	CcSEcCtD
Dactinomycin—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000298	0.00179	CcSEcCtD
Dactinomycin—Anorexia—Vincristine—lymphatic system cancer	0.000298	0.00179	CcSEcCtD
Dactinomycin—Body temperature increased—Bleomycin—lymphatic system cancer	0.000297	0.00178	CcSEcCtD
Dactinomycin—Anorexia—Mitoxantrone—lymphatic system cancer	0.000291	0.00174	CcSEcCtD
Dactinomycin—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000285	0.00171	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000285	0.00171	CcSEcCtD
Dactinomycin—Decreased appetite—Carmustine—lymphatic system cancer	0.000285	0.00171	CcSEcCtD
Dactinomycin—Pain—Carmustine—lymphatic system cancer	0.00028	0.00168	CcSEcCtD
Dactinomycin—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.000278	0.00167	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000278	0.00167	CcSEcCtD
Dactinomycin—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000277	0.00166	CcSEcCtD
Dactinomycin—Decreased appetite—Vincristine—lymphatic system cancer	0.000272	0.00163	CcSEcCtD
Dactinomycin—Feeling abnormal—Carmustine—lymphatic system cancer	0.00027	0.00162	CcSEcCtD
Dactinomycin—Fatigue—Vincristine—lymphatic system cancer	0.00027	0.00162	CcSEcCtD
Dactinomycin—Asthenia—Bleomycin—lymphatic system cancer	0.000269	0.00162	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000268	0.00161	CcSEcCtD
Dactinomycin—Pain—Vincristine—lymphatic system cancer	0.000268	0.00161	CcSEcCtD
Dactinomycin—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000265	0.00159	CcSEcCtD
Dactinomycin—Fatigue—Mitoxantrone—lymphatic system cancer	0.000263	0.00158	CcSEcCtD
Dactinomycin—Pain—Mitoxantrone—lymphatic system cancer	0.000261	0.00156	CcSEcCtD
Dactinomycin—Abdominal pain—Carmustine—lymphatic system cancer	0.000259	0.00156	CcSEcCtD
Dactinomycin—Body temperature increased—Carmustine—lymphatic system cancer	0.000259	0.00156	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000256	0.00154	CcSEcCtD
Dactinomycin—Pancytopenia—Methotrexate—lymphatic system cancer	0.000254	0.00152	CcSEcCtD
Dactinomycin—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000251	0.00151	CcSEcCtD
Dactinomycin—Neutropenia—Methotrexate—lymphatic system cancer	0.00025	0.0015	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000249	0.0015	CcSEcCtD
Dactinomycin—Abdominal pain—Vincristine—lymphatic system cancer	0.000247	0.00148	CcSEcCtD
Dactinomycin—Body temperature increased—Vincristine—lymphatic system cancer	0.000247	0.00148	CcSEcCtD
Dactinomycin—Hypersensitivity—Carmustine—lymphatic system cancer	0.000242	0.00145	CcSEcCtD
Dactinomycin—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000241	0.00145	CcSEcCtD
Dactinomycin—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000241	0.00145	CcSEcCtD
Dactinomycin—Pneumonia—Methotrexate—lymphatic system cancer	0.000239	0.00144	CcSEcCtD
Dactinomycin—Vomiting—Bleomycin—lymphatic system cancer	0.000239	0.00143	CcSEcCtD
Dactinomycin—Rash—Bleomycin—lymphatic system cancer	0.000237	0.00142	CcSEcCtD
Dactinomycin—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000236	0.00142	CcSEcCtD
Dactinomycin—Asthenia—Carmustine—lymphatic system cancer	0.000235	0.00141	CcSEcCtD
Dactinomycin—Stomatitis—Methotrexate—lymphatic system cancer	0.000232	0.00139	CcSEcCtD
Dactinomycin—Hypersensitivity—Vincristine—lymphatic system cancer	0.000231	0.00138	CcSEcCtD
Dactinomycin—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000225	0.00135	CcSEcCtD
Dactinomycin—Asthenia—Vincristine—lymphatic system cancer	0.000225	0.00135	CcSEcCtD
Dactinomycin—Diarrhoea—Carmustine—lymphatic system cancer	0.000224	0.00135	CcSEcCtD
Dactinomycin—Nausea—Bleomycin—lymphatic system cancer	0.000223	0.00134	CcSEcCtD
Dactinomycin—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000222	0.00133	CcSEcCtD
Dactinomycin—Asthenia—Mitoxantrone—lymphatic system cancer	0.000219	0.00131	CcSEcCtD
Dactinomycin—Diarrhoea—Vincristine—lymphatic system cancer	0.000214	0.00129	CcSEcCtD
Dactinomycin—Hepatitis—Methotrexate—lymphatic system cancer	0.000214	0.00128	CcSEcCtD
Dactinomycin—Pharyngitis—Methotrexate—lymphatic system cancer	0.000212	0.00127	CcSEcCtD
Dactinomycin—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000209	0.00125	CcSEcCtD
Dactinomycin—Vomiting—Carmustine—lymphatic system cancer	0.000208	0.00125	CcSEcCtD
Dactinomycin—Rash—Carmustine—lymphatic system cancer	0.000207	0.00124	CcSEcCtD
Dactinomycin—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000202	0.00121	CcSEcCtD
Dactinomycin—Vomiting—Vincristine—lymphatic system cancer	0.000199	0.00119	CcSEcCtD
Dactinomycin—Rash—Vincristine—lymphatic system cancer	0.000197	0.00118	CcSEcCtD
Dactinomycin—Nausea—Carmustine—lymphatic system cancer	0.000195	0.00117	CcSEcCtD
Dactinomycin—Vomiting—Mitoxantrone—lymphatic system cancer	0.000194	0.00116	CcSEcCtD
Dactinomycin—Rash—Mitoxantrone—lymphatic system cancer	0.000192	0.00115	CcSEcCtD
Dactinomycin—Chills—Methotrexate—lymphatic system cancer	0.000192	0.00115	CcSEcCtD
Dactinomycin—Alopecia—Methotrexate—lymphatic system cancer	0.000189	0.00113	CcSEcCtD
Dactinomycin—Erythema—Methotrexate—lymphatic system cancer	0.000186	0.00112	CcSEcCtD
Dactinomycin—Nausea—Vincristine—lymphatic system cancer	0.000186	0.00112	CcSEcCtD
Dactinomycin—Nausea—Mitoxantrone—lymphatic system cancer	0.000181	0.00109	CcSEcCtD
Dactinomycin—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000173	0.00104	CcSEcCtD
Dactinomycin—Anaemia—Methotrexate—lymphatic system cancer	0.000172	0.00103	CcSEcCtD
Dactinomycin—Malaise—Methotrexate—lymphatic system cancer	0.000168	0.00101	CcSEcCtD
Dactinomycin—Leukopenia—Methotrexate—lymphatic system cancer	0.000167	0.001	CcSEcCtD
Dactinomycin—Myalgia—Methotrexate—lymphatic system cancer	0.000158	0.000951	CcSEcCtD
Dactinomycin—Discomfort—Methotrexate—lymphatic system cancer	0.000156	0.000939	CcSEcCtD
Dactinomycin—Infection—Methotrexate—lymphatic system cancer	0.000151	0.000905	CcSEcCtD
Dactinomycin—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000149	0.000892	CcSEcCtD
Dactinomycin—Anorexia—Methotrexate—lymphatic system cancer	0.000145	0.000869	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000138	0.00083	CcSEcCtD
Dactinomycin—Decreased appetite—Methotrexate—lymphatic system cancer	0.000132	0.000792	CcSEcCtD
Dactinomycin—Fatigue—Methotrexate—lymphatic system cancer	0.000131	0.000786	CcSEcCtD
Dactinomycin—Pain—Methotrexate—lymphatic system cancer	0.00013	0.000779	CcSEcCtD
Dactinomycin—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000125	0.000751	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000124	0.000745	CcSEcCtD
Dactinomycin—Abdominal pain—Methotrexate—lymphatic system cancer	0.00012	0.00072	CcSEcCtD
Dactinomycin—Body temperature increased—Methotrexate—lymphatic system cancer	0.00012	0.00072	CcSEcCtD
Dactinomycin—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000112	0.000671	CcSEcCtD
Dactinomycin—Asthenia—Methotrexate—lymphatic system cancer	0.000109	0.000654	CcSEcCtD
Dactinomycin—Diarrhoea—Methotrexate—lymphatic system cancer	0.000104	0.000624	CcSEcCtD
Dactinomycin—Vomiting—Methotrexate—lymphatic system cancer	9.65e-05	0.000579	CcSEcCtD
Dactinomycin—Rash—Methotrexate—lymphatic system cancer	9.57e-05	0.000575	CcSEcCtD
Dactinomycin—Nausea—Methotrexate—lymphatic system cancer	9.02e-05	0.000541	CcSEcCtD
